Hims & Hers Health, Inc. (NYSE: HIMS), the leading global health and wellness platform, today announced the appointment of Kathryn Beiser as Chief Communications Officer. In this role, Beiser will ...

Novo dropped its patent-infringement case against telehealth provider Hims & Hers after the companies agreed that Hims would ...

On February 17, 2026, BLKBRD Asset Management, LP, disclosed it sold out its entire stake in Hims & Hers Health (HIMS +5.89%), an estimated $18.07 million trade based on quarterly ...

BofA Securities analyst Allen Lutz upgraded Hims and Hers from Underperform to Neutral with a price target of $23.00, up from $12.50. The analyst raised the price objective to reflect a 23x CY26E ...

Shares of telehealth company Hims & Hers skyrocketed Monday after the company struck a deal with Danish drugmaker Novo Nordisk to sell its GLP-1 weight-loss medications, ending the feud between the ...

Hims & Hers shares are up over 40% on Monday after announcing a deal with Novo Nordisk.

Wall Street's major averages ended lower on Friday after nonfarm payrolls unexpectedly contracted in February and oil prices continued to rise. The benchmark S&P 500 closed -1.3%, while the Nasdaq ...

Wondering whether Hims & Hers Health is starting to look attractively priced, or if the market is still getting ahead of ...